Mechanisms by which thiazolidinediones enhance insulin action

  • Reginato M
  • Lazar M
  • 26


    Mendeley users who have this article in their library.
  • 80


    Citations of this article.


Thiazolidinediones (TZDs) are an exciting new class of insulin- sensitizing drugs being used currently for the treatment of non-insulin- dependent diabetes mellitus. The molecular target of these compounds is thought to be the nuclear hormone receptor, peroxisome proliferator-activated receptor γ (PPARγ). PPARγ is expressed predominantly in adipose tissue, yet a major site of TZD-responsive glucose disposal is skeletal muscle. Potential explanations for this paradox are discussed in this review.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Mauricio J. Reginato

  • Mitchell A. Lazar

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free